Gilead CMO Dietmar Berger Converts RSUs; 263 Shares Withheld for Taxes

What Happened

• Dietmar Berger, Chief Medical Officer of Gilead Sciences (GILD), had 533 restricted stock units (RSUs) convert into common shares on 2026-09-10. To cover tax withholding, 263 of those shares were surrendered/withheld, resulting in a tax payment of $38,085 (263 shares × $144.81). The net result is approximately 270 shares delivered to Berger.

Key Details

• Transaction date: 2026-09-10; filing date: 2026-09-11 (timely).
• Reported actions/codes: M = exercise/conversion of derivative (533 RSUs converted); F = shares withheld to satisfy tax liability (263 shares disposed, $144.81 per share used for tax calculation).
• Shares acquired (converted): 533; shares withheld/disposed for taxes: 263; net shares delivered: ~270.
• Shares owned after transaction: not specified in the filing.
• Relevant footnotes: F1 — each RSU equals the right to one share; F2 — RSUs vest on a 4-year schedule (25% after one year, then 6.25% quarterly).
• No indication of an open-market sale or 10b5-1 plan; this appears to be routine tax withholding on vesting rather than a discretionary sale.

Context

• This transaction is a standard RSU vesting/conversion with shares withheld to cover taxes (a cashless-style settlement). Such withholding is common and typically does not signal an investment view. No purchase of additional shares was reported.